Adam Ghobarah
Angel Investor
San Francisco, United States
Adam Ghobarah is a seed investor in San Francisco focused on Analytics and Artificial Intelligence. Adam specializes in the effective application of data and analysis to improve products and transform large operations. At GV, he guides portfolio companies on data analysis and helps identify disruptive startups in the big data and analysis space.Over the past 15 years, Adam has applied statistics, machine learning, and big data to solveproblems in public health, engineering, finance, and most recently, online advertising. Adam joined Google in 2006 to direct a world-class team of statisticians focused on building models for predicting advertiser behavior and on automated model building and validation.Prior to joining Google, Adam worked at Mathsoft, which developed mathematical software tools for mechanical and civil engineers. Adam received his Ph.D. in statistics from the University of Texas at Austin and was a postdoctoral fellow at Harvard University, where he focused on the application of statistics to public health and authored several highly-cited papers.
- Total investments:
- 17
- Last investment:
- Lead investor:
- 53%
Last updated:
For AI agents: llms.txt
Industries Adam Ghobarah invests in
Stages Adam Ghobarah invests in
Countries Adam Ghobarah invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Analytics 5 (29%)
- Artificial Intelligence 5 (29%)
- Software 4 (24%)
- Cloud Data Services 3 (18%)
- Big Data 2 (12%)
Stage
- Seed 5 (29%)
- Series A 4 (24%)
- Series B 3 (18%)
- Series F 2 (12%)
- Series D 1 (6%)
Country
- United States 8 (47%)
- France 1 (6%)
- Indonesia 1 (6%)
- Switzerland 1 (6%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Hedera Dx
|
With the use of Hedera Dx's liquid biopsy solution, hospital labs will be able to conduct clinically useful liquid biopsies on their own. This will greatly simplify tumor profiling. It is difficult to accomplish IVD compliance, privacy infrastructure, and validation, and even if these challenges are overcome, the current software workflows areinefficient to use and lack key capabilities.Hedera Dx was established on July 1, 2021 in Epalinges, Vaud. | $17M / Series A / May 27, 2025 | |
Voxel51
|
Voxel51 is the leading data platform for physical AI. The company's flagship product, FiftyOne, combines open-source flexibility with enterprise-grade capabilities to help teams understand and analyze their multimodal data, annotate the right samples, close quality and coverage gaps, and build models that perform reliably in the real world.Trusted by millions of developers and thousands of enterprises—including Porsche, Vivint, Berkshire Grey, and Microsoft—FiftyOne is how the world's leading AI teams build the data foundation physical AI demands. Learn more at voxel51.com. | $30M / Series B / May 16, 2024 | |
Asaren
|
Asaren manages the mental health needs of their blue-chip clients' employees, with industries ranging from banking, energy, retail, and many others. They provide triage assessment, DNA testing, and online consultation with medical professionals. | $8.2M / Feb 09, 2023 | |
|
Asaren
|
Asaren manages the mental health needs of their blue-chip clients' employees, with industries ranging from banking, energy, retail, and many others. They provide triage assessment, DNA testing, and online consultation with medical professionals. | $8.2M / Seed / Feb 09, 2023 | |
|
Voxel51
|
Voxel51 is the leading data platform for physical AI. The company's flagship product, FiftyOne, combines open-source flexibility with enterprise-grade capabilities to help teams understand and analyze their multimodal data, annotate the right samples, close quality and coverage gaps, and build models that perform reliably in the real world.Trusted by millions of developers and thousands of enterprises—including Porsche, Vivint, Berkshire Grey, and Microsoft—FiftyOne is how the world's leading AI teams build the data foundation physical AI demands. Learn more at voxel51.com. | $12.5M / Series A / Sep 21, 2022 | |
|
Hedera Dx
|
With the use of Hedera Dx's liquid biopsy solution, hospital labs will be able to conduct clinically useful liquid biopsies on their own. This will greatly simplify tumor profiling. It is difficult to accomplish IVD compliance, privacy infrastructure, and validation, and even if these challenges are overcome, the current software workflows areinefficient to use and lack key capabilities.Hedera Dx was established on July 1, 2021 in Epalinges, Vaud. | $14M / Seed / Sep 20, 2022 | |
SingleStore
|
SingleStore is a provider of a database for operational analytics and cloud-native applications. It provides global enterprises with an intelligent database that works on any cloud on-premises or as a service runs transactions and analytics at the same time and lets clients promote their business through analytics and combine semi-structured datainto a consolidated big data platform.The company was founded in 2011 and is headquartered in San Francisco, California. | $116M / Series F / Jul 12, 2022 | |
SingleStore
|
SingleStore is a provider of a database for operational analytics and cloud-native applications. It provides global enterprises with an intelligent database that works on any cloud on-premises or as a service runs transactions and analytics at the same time and lets clients promote their business through analytics and combine semi-structured datainto a consolidated big data platform. | $116M / Series F / Jul 12, 2022 | |
Kinetix
|
Kinetix is a no-code 3D creation tool that leverages artificial intelligence motion capture to convert videos into 3D animations. | $11M / Seed / May 04, 2022 | |
|
Kinetix
|
Kinetix is a no-code 3D creation tool that leverages artificial intelligence motion capture to convert videos into 3D animations. | $11M / Seed / May 04, 2022 | |
| See all 17 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Adam Ghobarah invest in?
Adam Ghobarah invests primarily in Analytics, Artificial Intelligence and Software startups, most often at Seed and Series A stage. Most of the 17 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Adam Ghobarah?
Public channels for Adam Ghobarah include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Adam Ghobarah last invest?
The most recent investment recorded for Adam Ghobarah closed in May 2025. Shizune tracks 17 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
